Description:

Thank You to our Sponsor!

The Respiratory Syncytial Virus (RSV) is a highly contagious seasonal virus. By the age of two, >90% of children will have at least one RSV infection. RSV is the leading cause of lower respiratory tract infections in infants with significant morbidity and a risk of hospitalization. Novel RSV prevention strategies have emerged as a potential game-changer in the field, offering an innovative approach to RSV prevention. This presentation will provide a comprehensive overview of RSV, its impact on babies in Canada, and the science behind RSV prevention. By shedding light on these innovative therapeutic advancements, we aim to underscore the importance of continued research and collaboration in the fight against RSV and its potential to transform pediatric healthcare.